October 28th, 2015
According to new research data, published in Cellular and Molecular Gastroenterology and Hepatology, intra-abdominal fat cells may play a role in the pathophysiology of inflammatory bowel disease. Dr. David Bruining, M.D., explains the study. Fat accumulation surrounding the inflamed intestine, (also known as ‘creeping fat’ or mesenteric fat), during Crohn’s disease represents a hallmark of the disease. In […]
April 23rd, 2015
David Bruining, M.D., discusses a recent study published in Gastroenterology about a new measuring index for Crohn’s disease progression. The Lémann Index is the first comprehensive scoring index to assess bowel damage from Crohn’s disease. For more information about IBD, visit mayoclinic.org/IBD. Dr. Bruining is a gastroenterologist at Mayo Clinic.
March 26th, 2014
David Bruining, M. D., discusses a recent study published in the Inflammatory Bowel Diseases journal about Crohn’s disease strictures. The study results highlight a move toward noninvasive or non-surgical approaches for Crohn’s disease patients. Crohn’s disease initially begins as an inflammatory process. For many patients, it grows to be fibrostenotic disease manifesting in strictures. Endoscopic dilatation […]
March 14th, 2014
David Bruining, M. D., discusses a recent study published in the American Journal of Gastroenterology about diffusion-weighted magnetic resonance imaging in inflammatory bowel disease. Diffusion-weighted imaging (DWI) is a new method of assessing the small bowel in patients with Crohn’s disease. What’s unique about this study is researchers from France looked at 130 patients with Crohn’s […]